Poster presented at ICTMC 2022 conference.  This study aims to compare different methods for the analysis of the SF-36 domain scores in randomised controlled trials using standardised effect size to unify and compare their estimated values with evidence from empirical analyses.  The ethics approval for this secondary analysis of data was obtained from the University of Sheffield ScHARR Ethics Committee (Reference 036168).